Search company, investor...

Predict your next investment

Angel Investor (Individual)

Investments

51

Portfolio Exits

4

About Jonathan Milner

Headquarters Location

United Kingdom

Want to inform investors similar to Jonathan Milner about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Jonathan Milner

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Jonathan Milner in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest Jonathan Milner News

Abcam founder considering options to regain company amid takeover - report

Sep 20, 2023

gorodenkoff/iStock via Getty Images Abcam (NASDAQ: ABCM ) founder Jonathan Milner is looking at various options to try to regain control of the companyas he opposses the current $24 a share takeover from Danaher (NYSE: DHR ). Abcam ticked up 0.4%. Milner indicated last week in a statement that he plans to request that the company convene a general meeting to replace the company's board, though he hasn't submitted a request yet and it's not clear when he will, according to an Equity Report on Wednesday, which cited a person familiar with the matter. Milner is also discussing the situation with other shareholders. Milner's plan is expected to include keeping Abcam's ( ABCM ) Nasdaq listing while adding back a Main Market listing on the London Stock Exchange, according to the report. Milner's options for Abcam ( ABCM ) may be fairly limited, according to the Equity Report, which cited a lawyer who said that Milner's only real option is to persuade other holders to block the scheme of arrangement. Milner last Thursday said his decision to oppose the Danaher ( DHR ) sale came after he received "extensive" feedback from many holders and analysts that the $24 a share deal "substantially undervalues" Abcam ( ABCM ). Abcam CEO Alan Hirzel on Thursday responded to Milner's plan to vote down the $24 a share takeover. It's "odd to make this choice before you see the facts of the rigorous process that was followed and as you noted in your link above," Hirzel said in a post on LinkedIn i n a response to Milner. "The shareholder circular will make everything clear to shareholders who want the facts."

Jonathan Milner Investments

51 Investments

Jonathan Milner has made 51 investments. Their latest investment was in PharmEnable as part of their Seed VC - II on May 5, 2023.

CBI Logo

Jonathan Milner Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/19/2023

Seed VC - II

PharmEnable

$7.5M

No

5

3/27/2023

Series B

SolasCure

$13.3M

No

BRAIN, Eva Pharmaa, Jonathan Milner, Seneca Partners, Undisclosed Angel Investors, Undisclosed Venture Investors, and Wealth Club

5

7/6/2022

Series B - II

Nuclera

$15.5M

Yes

1

6/14/2022

Seed VC - IV

Subscribe to see more

$99M

Subscribe to see more

10

6/9/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/19/2023

3/27/2023

7/6/2022

6/14/2022

6/9/2022

Round

Seed VC - II

Series B

Series B - II

Seed VC - IV

Seed VC

Company

PharmEnable

SolasCure

Nuclera

Subscribe to see more

Subscribe to see more

Amount

$7.5M

$13.3M

$15.5M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

BRAIN, Eva Pharmaa, Jonathan Milner, Seneca Partners, Undisclosed Angel Investors, Undisclosed Venture Investors, and Wealth Club

Sources

5

5

1

10

10

Jonathan Milner Portfolio Exits

4 Portfolio Exits

Jonathan Milner has 4 portfolio exits. Their latest portfolio exit was Valence on May 08, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/8/2023

Acquired

$99M

2

2/1/2023

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/14/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

3/24/2014

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/8/2023

2/1/2023

6/14/2021

3/24/2014

Exit

Acquired

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.